Bernocchi Perry A's Form 4 filing
Accendra Health IncACH · filed Jun 7, 2024
- Accession no.
- 0001062993-24-012194
- Filed
- Jun 7, 2024
- Trade date
- Jun 6, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $350.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bernocchi Perry ACIK 0001967402 | Officer (EVP, CEO,. Patient Direct) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | Common Stock | SSaleDisposed | −1,884 | $17.47F2 | −$32,913.48 | 147,651 | Direct | |
| Jun 6, 2024 | Common Stock | SSaleDisposed | −10,756 | $17.49F3 | −$188,122.44 | 136,895 | Direct | |
| Jun 6, 2024 | Common Stock | SSaleDisposed | −4,542 | $17.49F4 | −$79,439.58 | 132,353 | Direct | |
| Jun 6, 2024 | Common Stock | SSaleDisposed | −2,833 | $17.48F5 | −$49,520.84 | 129,520 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Weighted average of the sale price range of $17.30 - $17.76
Referenced by the price of 1 transaction in Table I.
- F3
Weighted average of the sale price range of $17.285 - $17.78
Referenced by the price of 1 transaction in Table I.
- F4
Weighted average of the sale price range of $17.30 - $17.77
Referenced by the price of 1 transaction in Table I.
- F5
Weighted average of the sale price range of $17.30 - $17.75
Referenced by the price of 1 transaction in Table I.